2019
DOI: 10.15420/cfr.2019.12.2
|View full text |Cite
|
Sign up to set email alerts
|

State-of-the-art Structural Interventions in Heart Failure

Abstract: Heart failure (HF) is a leading cause of hospitalisation and healthcare costs worldwide. Acute decompensated heart failure accounts for more than 1 million hospitalisations in the US. Despite advances in the quality of acute and chronic HF disease management, gaps in knowledge about effective interventions to support the transition of care for patients with HF remain. Despite multiple trials of promising therapies, standard care consists of decongestion with IV diuretics and haemodynamic support with vasodilat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 48 publications
0
7
0
Order By: Relevance
“…(E) shows an AVP3 being placed across the leak. (F) shows the device being released after confirmation of minimal leak and optimum functionality using echocardiography 46 …”
Section: Available Management Optionsmentioning
confidence: 99%
See 1 more Smart Citation
“…(E) shows an AVP3 being placed across the leak. (F) shows the device being released after confirmation of minimal leak and optimum functionality using echocardiography 46 …”
Section: Available Management Optionsmentioning
confidence: 99%
“…52 Mechanical shows the device being released after confirmation of minimal leak and optimum functionality using echocardiography. 46 valves require life-long anticoagulation therapy and there is also the risk of bleeding, whereas with bioprosthetic valves, life-long anticoagulation therapy is not needed but they are more likely to degenerate and will fail with time. 53 A 2016 study reviewing 460…”
Section: Surgical Managementmentioning
confidence: 99%
“…Transcatheter pulmonary valve replacement is an alternative to surgery in patients with dysfunctional right ventricle-pulmonary artery conduits or bioprosthetic valves. 68,69 It is also useful in patients who cannot undergo open-heart surgery, such as pregnant women. 70 TTE and TEE remain the first-line imaging modalities for the assessment of transcatheter gradient or evidence of patient prosthesis mismatch.…”
Section: Pulmonary Valvementioning
confidence: 99%
“…4 Novel percutaneous therapies may be effective in selected patients but remain understudied in the acute setting and are generally considered a compassionate use indication. 22 Given the complex decision-making required for management of SHD emergencies, referral to a comprehensive valve center with proficiency in both surgical and percutaneous interventions for SHD should be considered. 23 Medical therapy may be definitive in thrombosis of a native or (more commonly) prosthetic valve; when valve thrombosis is suspected or confirmed, a trial of aggressive antithrombotic therapy starting with high-intensity heparin may be effective.…”
Section: General Considerationsmentioning
confidence: 99%